Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD.
Bandelow B, Allgulander C, Baldwin DS, Costa DLDC, Denys D, Dilbaz N, Domschke K, Hollander E, Kasper S, Möller HJ, Eriksson E, Fineberg NA, Hättenschwiler J, Kaiya H, Karavaeva T, Katzman MA, Kim YK, Inoue T, Lim L, Masdrakis V, Menchón JM, Miguel EC, Nardi AE, Pallanti S, Perna G, Rujescu D, Starcevic V, Stein DJ, Tsai SJ, Van Ameringen M, Vasileva A, Wang Z, Zohar J. Bandelow B, et al. Among authors: starcevic v. World J Biol Psychiatry. 2023 Feb;24(2):118-134. doi: 10.1080/15622975.2022.2086296. Epub 2022 Jul 28. World J Biol Psychiatry. 2023. PMID: 35900217
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ; WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disoders; Zohar J, Hollander E, Kasper S, Möller HJ, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, Cassano G, Fineberg N, Gabriels L, Hindmarch I, Kaiya H, Klein DF, Lader M, Lecrubier Y, Lépine JP, Liebowitz MR, Lopez-Ibor JJ, Marazziti D, Miguel EC, Oh KS, Preter M, Rupprecht R, Sato M, Starcevic V, Stein DJ, van Ameringen M, Vega J. Bandelow B, et al. Among authors: starcevic v. World J Biol Psychiatry. 2008;9(4):248-312. doi: 10.1080/15622970802465807. World J Biol Psychiatry. 2008. PMID: 18949648
Use of benzodiazepines in obsessive-compulsive disorder.
Starcevic V, Berle D, do Rosário MC, Brakoulias V, Ferrão YA, Viswasam K, Shavitt R, Miguel E, Fontenelle LF. Starcevic V, et al. Int Clin Psychopharmacol. 2016 Jan;31(1):27-33. doi: 10.1097/YIC.0000000000000100. Int Clin Psychopharmacol. 2016. PMID: 26426443
International prescribing practices in obsessive-compulsive disorder (OCD).
Brakoulias V, Starcevic V, Belloch A, Dell'Osso L, Ferrão YA, Fontenelle LF, Lochner C, Marazziti D, Martin A, Matsunaga H, Miguel EC, Reddy YC, do Rosário MC, Shavitt RG, Sundar AS, Stein DJ, Viswasam K. Brakoulias V, et al. Among authors: starcevic v. Hum Psychopharmacol. 2016 Jul;31(4):319-24. doi: 10.1002/hup.2541. Epub 2016 Jun 7. Hum Psychopharmacol. 2016. PMID: 27271200
Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): An international collaboration.
Brakoulias V, Starcevic V, Belloch A, Brown C, Ferrao YA, Fontenelle LF, Lochner C, Marazziti D, Matsunaga H, Miguel EC, Reddy YCJ, do Rosario MC, Shavitt RG, Shyam Sundar A, Stein DJ, Torres AR, Viswasam K. Brakoulias V, et al. Among authors: starcevic v. Compr Psychiatry. 2017 Jul;76:79-86. doi: 10.1016/j.comppsych.2017.04.002. Epub 2017 Apr 12. Compr Psychiatry. 2017. PMID: 28433854
Treatments used for obsessive-compulsive disorder-An international perspective.
Brakoulias V, Starcevic V, Albert U, Arumugham SS, Bailey BE, Belloch A, Borda T, Dell'Osso L, Elias JA, Falkenstein MJ, Ferrao YA, Fontenelle LF, Jelinek L, Kalogeraki L, Kay B, Laurito LD, Lochner C, Maina G, Marazziti D, Martin A, Matsunaga H, Miguel EC, Morgado P, Mourikis I, Pasquini M, Perez Rivera R, Potluri S, Reddy JYC, Riemann BC, do Rosario MC, Shavitt RG, Stein DJ, Viswasam K, Wang Z, Fineberg NA. Brakoulias V, et al. Among authors: starcevic v. Hum Psychopharmacol. 2019 Jan;34(1):e2686. doi: 10.1002/hup.2686. Epub 2019 Jan 10. Hum Psychopharmacol. 2019. PMID: 30628745
Lormetazepam in oral solution: a formulation at risk of high-dose use.
Cosci F, Nardi AE, Starcevic V, Chouinard G, Balon R. Cosci F, et al. Among authors: starcevic v. Intern Emerg Med. 2019 Nov;14(8):1203-1204. doi: 10.1007/s11739-019-02143-y. Epub 2019 Jul 3. Intern Emerg Med. 2019. PMID: 31270679 No abstract available.
Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment.
Quagliato LA, Cosci F, Shader RI, Silberman EK, Starcevic V, Balon R, Dubovsky SL, Salzman C, Krystal JH, Weintraub SJ, Freire RC, Nardi AE; International Task Force on Benzodiazepines. Quagliato LA, et al. Among authors: starcevic v. J Psychopharmacol. 2019 Nov;33(11):1340-1351. doi: 10.1177/0269881119859372. Epub 2019 Jul 15. J Psychopharmacol. 2019. PMID: 31304840
The rates of co-occurring behavioural addictions in treatment-seeking individuals with obsessive-compulsive disorder: a preliminary report.
Brakoulias V, Starcevic V, Albert U, Arumugham SS, Bailey BE, Belloch A, Borda T, Dell'Osso L, Elias JA, Falkenstein MJ, Ferrao YA, Fontenelle LF, Jelinek L, Kay B, Lochner C, Maina G, Marazziti D, Matsunaga H, Miguel EC, Morgado P, Pasquini M, Perez-Rivera R, Potluri S, Reddy JYC, Riemann BC, do Rosario MC, Shavitt RG, Stein DJ, Viswasam K, Fineberg NA. Brakoulias V, et al. Among authors: starcevic v. Int J Psychiatry Clin Pract. 2020 Jun;24(2):173-175. doi: 10.1080/13651501.2019.1711424. Epub 2020 Jan 9. Int J Psychiatry Clin Pract. 2020. PMID: 31916881
272 results